Impact of immunophenotyping on management of acute leukemias.

Oncogenic Transcription Factors in the Human Acute Leukemias

1997 • 1,227 citations

Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

1984 • 1,193 citations

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

1996 • 907 citations

Immunologic classification of leukemia and lymphoma.

1986 • 773 citations

The Leukocyte Common Antigen Family

1989 • 741 citations

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]

1992 • 507 citations

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1998 • 467 citations

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

1996 • 398 citations

Homing Receptors and Vascular Addressins: Cell Adhesion Molecules that Direct Lymphocyte Traffic

1989 • 332 citations

Immunophenotyping of Acute Leukemia by Flow Cytometric Analysis:Use of CD45 and Right-Angle Light Scatter to Gate on Leukemic Blasts in Three-Color Analysis

1993 • 315 citations

Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome

1993 • 294 citations

Immunophenotyping Investigation of Minimal Residual Disease Is a Useful Approach for Predicting Relapse in Acute Myeloid Leukemia Patients

1997 • 271 citations

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1999 • 237 citations

Expression of the Neural Cell Adhesion Molecule CD56 Is Associated With Short Remission Duration and Survival in Acute Myeloid Leukemia With t(8; 21)(q22; q22)

1997 • 234 citations

Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]

1993 • 213 citations

Definition of acute biphenotypic leukemia.

1997 • 206 citations

HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3 [see comments]

1994 • 202 citations

Immunophenotypic and Genotypic Features,Clinical Characteristics,and Treatment Outcome of Adult Pro-B acute Lymphoblastic Leukemia:Results of the German Multicenter Trials GMALL 03/87 and 04/89

1998 • 193 citations

Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies

1985 • 192 citations

Clinical Importance of Myeloid-Antigen Expression in Acute Lymphoblastic Leukemia of Childhood

1991 • 191 citations

Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group

1992 • 183 citations

Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia

1998 • 173 citations

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

1998 • 170 citations

Functional Analysis of Four Tetraspans, CD9, CD53, CD81, and CD82, Suggests a Common Role in Costimulation, Cell Adhesion, and Migration: Only CD9 Upregulates HB-EGF Activity

1997 • 160 citations

Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood Leukemia

1998 • 139 citations

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

1997 • 138 citations

Prognostic Significance of Fluorescence Intensity of Surface Marker Expression in Childhood B-Precursor Acute Lymphoblastic Leukemia. A Pediatric Oncology Group Study

1997 • 133 citations

Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia

1994 • 122 citations

Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.

1993 • 121 citations

Acute promyelocytic leukemia: a curable disease

1998 • 121 citations

Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia

1996 • 116 citations

Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).

1992 • 109 citations

Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia.

1998 • 101 citations

Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.

1990 • 100 citations

Performance of calibration standards for antigen quantitation with flow cytometry

1998 • 96 citations

P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.

1994 • 95 citations

Overexpression of lung‐resistance protein and increased P‐glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival

1998 • 94 citations

Association of bcl-2, bax, bcl-xL and interleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia.

1996 • 92 citations

Expression of Myeloid Markers Lacks Prognostic Impact in Children Treated for Acute Lymphoblastic Leukemia: Italian Experience in AIEOP-ALL 88-91 Studies

1998 • 91 citations

Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study

1998 • 86 citations

Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features [see comments]

1992 • 85 citations

Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes.

1996 • 82 citations

ACUTE PROMYELOCYTIC LEUKAEMIA

1992 • 81 citations

U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations

1997 • 80 citations

Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study

1989 • 77 citations

Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia

1998 • 68 citations

Detection of minimal residual disease in B‐lineage acute lymphoblastic leukaemia by quantitative flow cytometry

1998 • 67 citations

The majority of myeloid‐antigen‐positive (My⁺) childhood B‐cell precursor acute lymphoblastic leukaemias express TEL‐AML1 fusion transcripts

1997 • 64 citations

Acute Lymphoblastic Leukemia (ALL): Detection of Minimal Residual Disease (MRD) at Flow Cytometry

1994 • 60 citations

Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 cases

1997 • 59 citations

Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients

1998 • 51 citations

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

1992 • 49 citations

Functional Expression of Fas (CD95) in Acute Myeloid Leukemia Cells in the Context of CD34 and CD38 Expression: Possible Correlation With Sensitivity to Chemotherapy

1997 • 49 citations

Acute myeloid leukaemia expressing the leucocyte integrin CD11b — a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis

1998 • 49 citations

Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemia.

1993 • 47 citations

Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells

1997 • 43 citations

Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.

1995 • 42 citations

Neural Cell Adhesion Molecule (CD56)–Positive Acute Myelogenous Leukemia and Myelodysplastic and Myeloproliferative Syndromes

1997 • 42 citations

Characteristics of pro-T ALL subgroups: comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucémies.

1993 • 41 citations

A New Approach of Acute Lymphoblastic Leukemia Immunophenotypic Classification: 1984–1994 The GEIL Experience

1994 • 38 citations

CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study

1996 • 37 citations

8 Treatment of the elderly patient with acute myeloid leukaemia

1996 • 36 citations

Multidrug resistance in acute leukemia: a comparison of different diagnostic methods

1997 • 34 citations

Prognostic value of immunological markers in acute myeloblastic leukemia.

1989 • 33 citations

Expression of N-CAM (CD56) on Acute Leukemia Cells: Relationship with Disease Chracteristics and Outcome

1995 • 33 citations

Measuring multidrug resistance expression in human malignancies: elaboration of consensus recommendations.

1997 • 33 citations

Clinical, Morphologic, Cytogenetic and Prognostic Implications of CD34 Expression in Childhood and Adult de novo AML

1995 • 32 citations

Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.

1998 • 30 citations

Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells

1996 • 30 citations

Prognostic value of S‐phase cells in AML patients

1995 • 29 citations

Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow‐up of patients in clinical remission

1997 • 28 citations

Expression of intercellular adhesion molecule 1 (ICAM‐1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome

1997 • 28 citations

P-glycoprotein expression and prognostic value in acute myeloid leukemia.

1998 • 26 citations

Modern molecular diagnostics and the management of haematological malignancies

1998 • 26 citations

Prognostic Value of Immunophenotypic Characteristics of Blast Cells in Acute Myeloid Leukemia

1994 • 25 citations

PreB1 (CD10^-) Acute Lymphoblastic Leukemia: Immunophenotypic and Genomic Characteristics, Clinical Features and Outcome in 38 Adults and 26 Children

1998 • 24 citations

Differentiation therapy in acute promyelocytic leukemia: European experience

1997 • 24 citations

Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.

1995 • 23 citations

Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: Inverse correlation between expression and tumor progression

1996 • 22 citations

Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia

1997 • 22 citations

Immunological Definition of Acute Minimally Differentiated Myeloid Leukemia (MO) and Acute Undifferentiated Leukemia (AUL)

1995 • 20 citations

Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics

1997 • 17 citations

Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma.

1996 • 17 citations

Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in The Netherlands

1996 • 16 citations

CD34+ Leukemic Cells Assessed by Different CD:34 Monoclonal Antibodies

1995 • 16 citations

Expression and Long-Term Prognostic Value of CD34 in Childhood and Adult Acute Lymphoblastic Leukemia

1995 • 15 citations

Flow Cytometric Analysis of Intracellular Myeloperoxidase and Lactoferrin in Leukemia Diagnosis

1993 • 14 citations

Incidence, Clinical and Laboratory Features, and Prognostic Significance of Immunophenotypic Subgroups in Acute Lymphoblastic Leukemia: The GEIL Experience

1993 • 14 citations

The use of cytochemical procedures in the diagnosis and management of acute and chronic myeloid leukemia.

1990 • 12 citations

Intracellular markers in acute myeloid leukemia diagnosis.

1998 • 10 citations

Differences in CD14 and α-naphthyl acetate esterase positivity and relation to prognosis in AML

1998 • 10 citations

Photomultiplier voltage setting: Possible important source of variability in molecular equivalents of soluble fluorochrome (MESF) calculation?

1995 • 10 citations

Guidelines for the diagnosis of leukemia or lymphoma in children.

1998 • 10 citations

Multiphenotypic Acute Leukemias: Clinicopathologic Correlations and Response to Therapy

1992 • 9 citations

Levels of CAF7 (CD98) expression correlate with the complete remission duration in childhood acute leukemia

1996 • 5 citations

ACUTE MYELOBLASTIC LEUKAEMIA.

1963 • 3 citations

Application of the polymerase chain reaction for detection of minimal residual disease of hematologic malignancies.

1991 • 3 citations